Erratum: Cutaneous manifestations of metabolic diseases: Uncommon presentations (Clinics in Dermatology (2005) 23 (457-464) DOI: 10.1016/j.clindermatol.2005.01.008);Cutaneous manifestations of metabolic diseases: Uncommon presentations

Clinics in Dermatology

Volumn 23, Issue 5, 2005, Pages 457-464

  Köstler, Erich ^a   Porst, Heiner ^b   Wollina, Uwe ^b  

^a ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIDIABETIC AGENT; CALCIUM; COPPER; GLUTARIC ACID; GLYCOSAMINOGLYCAN; INSULIN; IRON; PORPHYRIN; ZINC;

ACRODERMATITIS ENTEROPATHICA; ALLERGY; ARTICLE; BLEEDING; CALCINOSIS; CARBOHYDRATE METABOLISM; CLINICAL FEATURE; COPPER METABOLISM; DIABETES MELLITUS; DIALYSIS; ERYTHEMA; FISTULA; GOUT; HAIR; HEMOCHROMATOSIS; HEPATIC PORPHYRIA; HISTOLOGY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; HYPERLIPIDEMIA; HYPERPIGMENTATION; IRON METABOLISM; LIPID METABOLISM; LIPIDOSIS; LIPOATROPHY; LIPOHYPERTROPHY; LIPOPROTEIN METABOLISM; MAROTEAUX LAMY SYNDROME; MENKES SYNDROME; METABOLIC DISORDER; MORQUIO SYNDROME; MUCINOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; MUCOSA; NAIL DISEASE; NECROSIS; OXALOSIS; PAPULE; PARATHYROIDECTOMY; PHOTOALLERGY; PIGMENT DISORDER; PORPHYRIA; PORPHYRIN METABOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RISK ASSESSMENT; SANFILIPPO SYNDROME; SCHEIE SYNDROME; SCLERODERMA; SKIN BURNING SENSATION; SKIN NODULE; TUMOR; ULCER; WILSON DISEASE; ZINC METABOLISM;

EID: 25144461132     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2005.10.023     Document Type: Erratum

References (100)

1. S. Solberg Die Haut als Spiegel innerer Erkrankungen Z Hautkr 73 1998 71
2. P.W. Broichmann, and G. Forck Relevanz von Dermatosen in der Diabetesdiagnostik: Eine Langzeitstudie Z Hautkr 67 1992 591 594
3. A.C. Huntley Cutaneous manifestations of diabetes mellitus Dermatol Clin 7 1989 531 546
4. L. Török Hauterscheinungen bei Erkrankungen innerer Organe 1997 Barth Heidelberg
5. L.H. Couterman, and L.A. Sibrack Cutaneous manifestations of diabetes Cutis 25 1980 45 53
6. O. Braun-Falco, G. Plewig, and H.H. Wolff Dermatology 2nd ed. 2000 Springer Berlin
7. R.R. Bab, D. Alarcon-Sergovia, and J.F. Fairbairn Erythromelalgia: review of 51 cases Circulation 21 1964 136 141
8. M. Leverkus, S. Wever, and E.B. Bröcker Primäre nichtfamiliäre Erythermalgie Akt Dermatol 27 2001 13 17
9. P. Priollet, P. Bruneval, and J. Lazareth Erythromelalgia: without arteriolar changes Ann Intern Med 103 1985 639 642
10. J.P. Drenth, and J.J. Michiels Three types of erythromelalgia BMJ 301 1990 454 455
11. H. Wolff Kutane Paraneoplasien Hautarzt 52 2001 159 172
12. S.M. Johnson, B.R. Smoller, and L.W. Lamps Necrolytic migratory erythema as the only presenting sign of a glucagonoma J Am Acad Dermatol 49 2003 325 328
13. R.A. Schwartz Glucagonoma and pseudoglucagonoma syndromes Int J Dermatol 36 1997 81 89
14. U. Wollina, and G. Schreiber Polyglandular autoimmune syndrome type II (Schmidt's syndrome) in patients with autoimmune connective tissue disorders J Eur Acad Dermatol Venereol 17 2003 371 372
15. J.L. Millns, N. Fenske, and M. Mc Cune Diabetes: What are the skin-deep signs? Geriatrics 36 1981 94 107
16. I. Pastinszky, and I. Rácz Hautveränderungen bei inneren Krankheiten vol. I-II 1974 Volk und Gesundheit Berlin
17. A.H. Mehregan, O.D. Schwartz, and C.L. Livingood Reactive perforating collagenosis Arch Dermatol 96 1967 277 282
18. B. Zelger, H. Hintner, and J. Aubock Acquired perforating dermatosis. Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis Arch Dermatol 127 1991 695 700
19. K. Krüger, B. Tebbe, and S. Klengel Erworbene reaktiv perforierende Dermatose. Erfolgreiche Behandlung mit Allopurinol in 2 Fällen Hautarzt 50 1999 115 120
20. S. Brunnberg, R.M. Trüeb, and M. Krasovec Morbus Kyrle bei Diabetes mellitus Z Hautkr 74 1999 413 415
21. A.C. Huntley The cutaneous manifestation of diabetes mellitus J Am Acad Dermatol 7 1982 427 455
22. A. Darvay, K.M. Acland, and R. Russel-Jones Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin Br J Dermatol 141 1999 725 727
23. E. Köstler, and U. Wollina Ulcerated necrobiosis lipoidica: a combined treatment approach with dermatosurgery and PUVA Int J Lower Extremity Wounds 2 2003 243 245
24. M. Tronnier, and H.H. Wolff Dermatosen mit granulomatöser Entzündung H. Kerl C. Garbe L. Cerroni Histopathologie der Haut 2003 Springer Berlin 213 238
25. H.K. Dabski, and R.K. Winkelmann Generalized granuloma annulare: clinical and laboratory findings in 100 patients J Am Acad Dermatol 20 1989 39 47
26. O.P. Hornstein Pannikulitis als Symptom innerer Krankheiten O. Braun-Falco J. Ring Fortschritte der Praktischen Dermatologie und Venerologie vol. 12 1990 Springer Berlin 167 177
27. D.L. Rieger-Johnson, J.S. Kaur, and E.A. Pfeifer Calciphylaxis associated with cholangio-carcinoma treated with low-molecular-weight heparin and vitamin K Mayo Clin Proc 76 2001 749 752
28. A.R. Mazhar, R.J. Johnson, and D. Gillen Risk factors and mortality associated with calciphylaxis in end-stage renal disease Kidney Int 60 2001 324 332
29. C. Gudacker, R. Dzingel, and E. Köstler Kalziphylaxie bei chronischer Niereninsuffizienz Z Wundheilng 21 2001 11 12
30. J. Tittelbach, T. Graefe, and U. Wollina Painful ulcers in calciphylaxis-combined treatment with maggot therapy and oral pentoxifylline J Dermatolog Treat 12 2001 211 214
31. J.E. Arch-Ferrer, S.W. Beenken, and L.W. Rue Therapy for calciphylaxis: an outcome analysis Surgery 134 2003 941 944
32. U. Wollina Der diabetische Fuß: Eine Übersicht für Dermatologen Z Hautkr 74 1999 265 270
33. M. Gfesser, W.-I. Worret, and J. Schneider Das diabetische Fußsyndrom Z Hautkr 69 1994 581 584
34. U. Michel, and O.P. Hornstein Akroosteopathia ulcero-mutilans der Füße. Klinik und Differential Diagnose Dtsch Med Wochenschr 107 1982 169 175
35. R.L. Horswell, J.A. Birke, and C.A. Patout A staged management diabetes foot program versus standard care: a 1-year cost and utilization comparison in a state public hospital system Arch Phys Med Rehabil 84 2003 1743 1746
36. M.E. Edmonds, M.P. Blundell, and M.E. Morris Improved survival of the diabetic foot: the role of a specialized foot clinic Q J Med 232 1986 763 771
37. G. Donhauser, T. Ruzicka, and O. Braun-Falco Benigne symmetrische Lipomatose, Launois-Bensaude Typ III und Bureau Barriére Syndrom Hautarzt 42 1991 311 314
38. N. Novak, W. Petrow, and Th. Bieber Benigne symmetrische Lipomatose Launois-Bensaude Typ II mit ausgeprägter Systembeteiligung und Psoriasis Hautarzt 51 2000 427 430
39. I.A. Harsch, P. Michaeli, and E.G. Hahn Launois-Bensaude syndrome in a female with type 2 diabetes Med Sci Monit 9 2003 CS5 CS8
40. P.Y. Venenci, F.C. Powel, and W.P.D. Su Scleroderma: a report of thirty three cases J Am Acad Dermatol 11 1984 128 134
41. G. Yosipovitch, K. Chuan Loh, and O. Beng Hock Medical pearl: scleroderma like skin changes in patients with diabetes mellitus J Am Acad Dermatol 48 2003 109 111
42. R. Renner Diabetische Cheiropathie und verwandte Krankheitsbilder Münch Med Wochenschr 141 1999 311 313
43. C.E. Orfanos, Y.D. Adler, and C.C. Zouboulis The SAHA syndrome Horm Res 54 2000 251 258
44. J. Turnbull, Y.D. Adler, and C.E. Orfanos Komplexe Endokrinopathie als Mischbild eines HAIRAN Syndroms mit metabolischem Syndrom und charakteristischem Phänotyp J Dtsch Dermatol Ges 1 Suppl. 1 2003 S146
45. C. Schöfl, T. Schill, and F. Geishövel Polyzystisches Ovarialsyndrom und Insulinsyndrom Dtsch Ärztebl 101 2004 A346 A351
46. W.H. Oertel, K. Stiasny, and T.C. Weter Restless-Legs-Syndrome. Die vergessene Krankheit Dtsch Ärztebl 97 2000 B2485 B2489
47. D.A. Herold, and G. Albrecht Lokale Lipohypertrophie unter Insulinbehandlung Hautarzt 44 1993 40 42
48. I.M. Braverman Skin signs of systemic disease 3rd ed. 1998 Saunders Philadelphia
49. W. Gertler Systematische Dermatologie und Grenzgebiete vol. I-III 1973 Thieme Leipzig
50. J.L. Goldstein, and M.S. Brown Familial hypercholesterolemia J.B. Stanbury J.B. Wyngaarden D.S.l. Frederickson Metabolic Basis of Inherited Disease 5th ed. 1983 Mc Graw Hill New York 671 712
51. M. Hanefeld Hyperlipoproteinämien M. Hanefeld Fettstoffwechselstörungen, Bedeutung, Erkennung und Behandlung vol. II 1995 G. Fischer Jena 97 114
52. S. Bundino, A.M. Zina, and F. Aloi Papular xanthoma Dermatologica 177 1988 382 385
53. R.K. Winkelmann Das normolipämische plane Xanthom und seine assoziierten Syndrome Hautarzt 34 1983 159 163
54. H. Schaarschmidt, A. Geyer, and U.A. Müller Normolipämische plane Xanthome Z Hautkr 68 1993 109 112
55. Y. Tsunemi, H. Ihn, and N. Hattori Multiple eruptive dermatofibromas with CD 34+ cells in a patient with hypertriglyceridemia Dermatology 207 2003 319 321
56. P. Radloff, H. Mensing, and D. Vieluf Nekrobiotisches Xanthogranulom bei Paraproteinämie und Borrelieninfektion Z Hautkr 67 1992 907 910
57. F.W. Tischendorf, C.H. Meyer, and C.W. Spraul Auge und Innere Medizin 2003 Schattauer Stuttgart
58. U. Gresser Diagnose und Therapie der Gicht Dtsch Ärztebl 100 2003 A2862 A2870
59. R. Wernick, C. Winkler, and S. Campell Tophi as the initial manifestation of gout. Report of six cases and review of the literature Arch Intern Med 152 1992 873 876
60. K.Y. Kim, R. Schumacher, and E. Hunsche A literature review of the epidemiology and treatment of acute gout Clin Ther 25 2003 1593 1617
61. E. Grosshans, G.A. Schneider, and W. Undeutsch Fallbericht einer Gichtpannikulitis Z Hautkr 75 2000 656 659
62. U. Wollina, E. Kauf, and J. Seidel Metabolische und endokrine Erkrankungen H. Traupe H. Hamm Pädiatrische Dermatologie 1999 Springer Berlin 605 651
63. K.L. Robey, J.F. Reck, and K.D. Giacomini Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease Dev Med Child Neurol 45 2003 167 171
64. A.H. Mehregan Calcinosis cutis: a review of the clinical forms and report of 75 cases Semin Dermatol 3 1984 53 61
65. J.S. Walsh, and J.A. Failey Calcifying disorders of the skin J Am Acad Dermatol 33 1995 693 706
66. T.R. Blattert, and A. Weckbach Tumoröse Kalzinose (Teutschländer-Erkrankung) Chirurgia 64 1999 592 594
67. S.G. Gehrke, and W. Stremmel Molekulargenetische Diagnostik bei der Hämochromatose Dtsch Med Wochenschr 124 1999 431 434
68. P.C. Adams, Y. Deugnier, and R. Moirand The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis Hepatology 25 1997 162 166
69. U. Stölzel, E. Köstler, and D. Schuppan Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda Arch Dermatol 139 2003 309 313
70. I.M. Braverman Skin signs of gastrointestinal disease Gastroenterology 124 2003 1595 1614
71. J. Seidel, L.B. Möller, and H.J. Mentzel Disturbed copper transport in humans. Part 1: Mutations of the ATP7A gene lead to Menkes disease and occipital horn syndrome Cell Mol Biol (Noisy-le-grand) 41 2001 OL141 OL148
72. J. Wohlrab, M. Fischer, and W.C. Marsch Livedo racemosa localisata als kutane Manifestation einer primären Oxalose Akt Dermatol 26 2000 362 365
73. M. Isonokami, K. Nishida, and N. Okada Cutaneous oxalate granulomas in a hemodialysed patient: report of a case with unique clinical features Br J Dermatol 128 1993 690 692
74. S. Saijo, K. Kudoh, and Y. Kuramoto Tyrosinemia II: report of an incomplete case and studies on the hyperkeratotic stratum corneum Dermatologica 182 1991 168 171
75. T. Salomon, M. Hrnjica, and U.W. Schnyder Vier Fälle von Richner-Hanhart-Syndrom (Tyrosinämie Typ II) mit neurologischer Symptomatologie in einer jugoslawischen Familie Hautarzt 39 1988 149 154
76. A. Ott, H.-P. Baum, and T. Waldmann Blaue Ohren bei Ochronose-eine Kasuistik Z Hautkr 75 2000 436 438
77. K. Assmann, G. Bonsmann, and D. Metze Akrodermatitis enteropathica- ähnliche Hautveränderungen bei Ahornsiruperkrankung Z Hautkr 76 2001 220 222
78. S.J. Potter, A. Lu, and B. Wilcken Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5 J Inherit Metab Dis 25 2002 437 448
79. R. Happle Neurocutaneous diseases J.M. Freedberg A.Z. Eisen K. Wolff Fitzpatrick's Dermatology in General Medicine 5th ed. 1999 Mc Graw-Hill New York 2131 2148
80. R.J. Desnick, R. Brady, and J. Barranger Fabry disease, an under-recognized multisystem disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy Ann Intern Med 138 2003 338 346
81. K.D. Mac Dermont, A. Holmes, and A.H. Miners Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males J Med Genet 38 2001 750 760
82. J. Frank, W. Jansen-Genzel, and A. Lentner Angiokeratoma corporis diffusum universale (Morbus Fabry) Hautarzt 74 1996 776 779
83. A.A. Raddadi, and A.A.A. Twaim Type A Niemann-Pick disease J Eur Acad Dermatol Venereol 14 2000 301 303
84. A.J. Wills, N.J. Manning, and M.M. Reilly Refsum's disease Q J Med 94 2001 403 406
85. J. Ai, J.M. Leonhardt, and W.R. Heymann Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations J Am Acad Dermatol 48 2003 641 659
86. P. Terheyden, and E.-B. Bröcker Hautveränderungen bei Schilddrüsenerkrankungen J Dtsch Dermatol Ges 1 2003 306 316
87. G. Moeser, L. Weber, and M. Kerscher Zirkumskriptes Myxödem der oberen und unteren Extremitäteneine seltene kutane Manifestation des Morbus Basedow Hautarzt 52 2001 439 443
88. H.-D. Göring, and A. Ziemer Immunpathogenetische, endokrinologische und therapeutische Probleme des EMO-Syndroms Dermatol Mon Schr 175 1989 492 498
89. M.R. Moore, K.E.L. Mc Coll, and C. Rimington Disorders of porphyrin metabolism 1987 Plenum New York
90. M.O. Doss Krankheiten und Störungen der Porphyrin- und Hämbiosynthese R. Gross P. Schölmerich W. Gerok Die Innere Medizin 9th ed. 1996 Schattauer Stuttgart 1002 1017
91. G.H. Elder The cutaneous porphyrias Semin Dermatol 9 1990 63 69
92. C. Fritsch, K. Bolsen, and T. Ruzicka Congenital erythropoietic porphyria J Am Acad Dermatol 36 1997 594 610
93. S. Ueda, N. Gulladalli, and J.A. Lo Cascio Corneal and conjunctival changes in congenital erythropoietic porphyria Cornea 8 1989 286 294
94. E. Köstler Die erythropoetische Protoporphyrie Dermatol Mon Schr 178 1992 274 281
95. M.O. Doss Hepatic porphyrias: pathobiochemical, diagnostic, and therapeutic implications H. Popper F. Schaffner Progress in Liver Diseases vol. VII 1982 Grune & Stratton New York 573 597
96. E. Köstler, and M. Doss Die chronische hepatische Porphyrie (Porphyria cutanea tarda) M. Brandis A. Fanconi P. Frick Advances in Internal Medicine and Pediatrics 1993 Springer Berlin 124 205
97. D. Creamer, J.M. Mc Gregor, and J. Mc Fadden Lichenoid reaction in porphyria cutanea tarda Br J Dermatol 141 1999 123 126
98. A. Martinez, R. Morales, and U. Brethauer Porphyria cutanea tarda affecting lower lip Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 2000 705 708
99. F.C.G. Shaffrali, A.J.G. Mc Donagh, and A.G. Messenger Hair darkening in porphyria cutanea tarda Br J Dermatol 146 2002 325 329
100. U. Stölzel, D. Schuppan, and H.L. Tillmannn Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study Cell Mol Biol (Noisy-le-grand) 48 2002 43 47